Precision medicine has begun to deliver important answers for patients who have diseases with a genetic component—cancer and some neurological diseases, in particular. But understanding how next-generation sequencing and emerging technologies can be applied to diagnosing, preventing, and treating certain conditions can be challenging without evidence of their effectiveness. Health plans are often reluctant to commit to reimbursing what they consider unproven treatment plans, and many are still undecided about covering certain types of genetic testing.

During this webinar you’ll learn more about the rapid progress being made in linking genetic testing and personalized medicine to better health outcomes. From oncology to neurological disorders like Alzheimer’s disease, the speakers will discuss the diseases that are seeing the greatest potential and those areas that are still emerging.

Featured Speakers

Patrick James, MD

Chief Clinical Officer, Health Plans and Policy
Quest Diagnostics

Patrick James, MD is Chief Clinical Officer, Health Plans and Policy, at Quest Diagnostics. Dr. James earned his medical degree with honors from St. Louis University. He completed his internship and residency training in anatomic and clinical pathology with board certification at the National Naval Medical Center and post-graduate training in cytopathology with board certification at Johns Hopkins Hospital. Dr. James has served in leadership positions at Quest Diagnostics and other leading healthcare organizations, as well as the U.S. Navy.

Felicitas L. Lacbawan, MD, FCAP, FACMG

VP and Executive Medical Director, Advanced Diagnostics
Quest Diagnostics

Prior to joining Quest, Dr. Lacbawan was the Section Head of Molecular Pathology at the Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic. Over her career, she has held various clinical, research and academic positions at the NHGRI-NIH, Children's National Medical Center, George Washington University School of Medicine and Health Sciences, SUNY-Downstate College of Medicine, and the Lombardi Cancer Center, Georgetown University Medical Center.

Bruce Quinn, MD, PhD

Bruce Quinn Associates LLC

Bruce Quinn MD PhD is a national expert on Medicare policy and genomics.  A pathologist by training, he worked in academic medicine until 2001 when he transitioned to a series of full time physician executive roles. He has worked for the Medicare program, for a global consulting firm, and for several Washington-based health policy firms.  He currently runs his own strategic consulting practice. 


Register now for this webinar